Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer’s disease. Nat Rev Dis Prim. 2015;1:15056. https://doi.org/10.1038/nrdp.2015.56.
Article
PubMed
Google Scholar
Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science (80- ). 2016;353(6301):777–83.
CAS
Google Scholar
Sochocka M, Diniz BS, Leszek J. Inflammatory response in the CNS: friend or foe? Mol Neurobiol. 2017;54(10):8071–89.
CAS
PubMed
Google Scholar
Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455–532.
PubMed
Google Scholar
Kaiser NC, Melrose RJ, Liu C, et al. Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer’s disease. Am J Alzheimer’s Dis Other Dementias®. 2012;27(7):520–9.
Google Scholar
Smits LL, Pijnenburg YAL, Koedam ELGE, et al. Early onset Alzheimer’s disease is associated with a distinct neuropsychological profile. J Alzheimers Dis. 2012;30(1):101–8.
PubMed
Google Scholar
Sá F, Pinto P, Cunha C, et al. Differences between early and late-onset Alzheimer’s disease in neuropsychological tests. Front Neurol. 2012;3:81.
PubMed
PubMed Central
Google Scholar
Panegyres PK, Chen H-Y. Differences between early and late onset Alzheimer’s disease. Am J Neurodegener Dis. 2013;2(4):300.
PubMed
PubMed Central
Google Scholar
Stanley K, Walker Z. Do patients with young onset Alzheimer’s disease deteriorate faster than those with late onset Alzheimer’s disease? A review of the literature. Int Psychogeriatrics. 2014;26(12):1945–53.
Google Scholar
Wattmo C, Wallin ÅK. Early-versus late-onset Alzheimer’s disease in clinical practice: cognitive and global outcomes over 3 years. Alzheimers Res Ther. 2017;9(1):70.
PubMed
PubMed Central
Google Scholar
Mendez MF. Early-onset Alzheimer disease and its variants. Contin Lifelong Learn Neurol. 2019;25(1):34–51.
Google Scholar
Balasa M, Gelpi E, Antonell A, et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology. 2011;76(20):1720–5.
CAS
PubMed
Google Scholar
Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL III. Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol. 2002;28(3):218–27.
PubMed
Google Scholar
Palasí A, Gutiérrez-Iglesias B, Alegret M, et al. Differentiated clinical presentation of early and late-onset Alzheimer’s disease: is 65 years of age providing a reliable threshold? J Neurol. 2015;262(5):1238–46.
PubMed
Google Scholar
Frisoni GB, Testa C, Sabattoli F, Beltramello A, Soininen H, Laakso MP. Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry. 2005;76(1):112–4.
CAS
PubMed
PubMed Central
Google Scholar
Cerami C, Dodich A, Greco L, et al. The role of single-subject brain metabolic patterns in the early differential diagnosis of primary progressive aphasias and in prediction of progression to dementia. J Alzheimers Dis. 2017;55(1):183–97.
PubMed
Google Scholar
Perani D, Della Rosa PA, Cerami C, et al. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. NeuroImage Clin. 2014;6:445–54. https://doi.org/10.1016/j.nicl.2014.10.009.
Article
PubMed
PubMed Central
Google Scholar
Vanhoutte M, Lopes R, Maureille A, et al. Hypometabolism patterns using FDG-PET in typical and atypical sporadic forms of early-onset Alzheimer’s disease. Alzheimers Dement. 2016;12(7):P532. https://doi.org/10.1016/j.jalz.2016.06.1041.
Article
Google Scholar
Caminiti SP, Ballarini T, Sala A, et al. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort. NeuroImage Clin. 2018;18:167–77.
PubMed
PubMed Central
Google Scholar
Iaccarino L, Chiotis K, Alongi P, et al. A cross-validation of FDG-and amyloid-PET biomarkers in mild cognitive impairment for the risk prediction to dementia due to Alzheimer’s disease in a clinical setting. J Alzheimers Dis. 2017;59(2):603–14.
CAS
PubMed
Google Scholar
Perani D, Cerami C, Caminiti SP, et al. Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. Eur J Nucl Med Mol Imaging. 2016;43(3):499–508.
CAS
PubMed
Google Scholar
Cerami C, Della Rosa PA, Magnani G, et al. Brain metabolic maps in mild cognitive impairment predict heterogeneity of progression to dementia. NeuroImage Clin. 2015;7:187–94.
PubMed
Google Scholar
Rabinovici GD, Furst AJ, Alkalay A, et al. Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden. Brain. 2010;133(2):512–28.
PubMed
PubMed Central
Google Scholar
Chiaravalloti A, Koch G, Toniolo S, et al. Comparison between early-onset and late-onset Alzheimer’s disease patients with amnestic presentation: CSF and 18F-FDG PET study. Dement Geriatr Cogn Dis Extra. 2016;6(1):108–19.
PubMed
PubMed Central
Google Scholar
Kim EJ, Cho SS, Jeong Y, et al. Glucose metabolism in early onset versus late onset Alzheimer’s disease: an SPM analysis of 120 patients. Brain. 2005;128(8):1790–801.
CAS
PubMed
Google Scholar
Vanhoutte M, Semah F, Sillaire AR, et al. 18F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer’s disease. Neurobiol Aging. 2017;59:184–96.
CAS
PubMed
Google Scholar
Ballarini T, Iaccarino L, Magnani G, et al. Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer’s disease. Hum Brain Mapp. 2016;37(12):4234–47.
PubMed
PubMed Central
Google Scholar
Sala A, Perani D. Brain molecular connectivity in neurodegenerative diseases: recent advances and new perspectives using positron emission tomography. Front Neurosci. 2019;13:617.
PubMed
PubMed Central
Google Scholar
Passow S, Specht K, Adamsen TC, et al. Default-mode network functional connectivity is closely related to metabolic activity. Hum Brain Mapp. 2015;36(6):2027–38.
PubMed
PubMed Central
Google Scholar
Horwitz B, Duara R, Rapoport SI. Intercorrelations of glucose metabolic rates between brain regions: application to healthy males in a state of reduced sensory input. J Cereb Blood Flow Metab. 1984;4(4):484–99.
CAS
PubMed
Google Scholar
Morbelli S, Drzezga A, Perneczky R, et al. Resting metabolic connectivity in prodromal Alzheimer’s disease. A European Alzheimer Disease Consortium (EADC) project. Neurobiol Aging. 2012;33(11):2533–50.
PubMed
Google Scholar
Malpetti M, Ballarini T, Presotto L, et al. Gender differences in healthy aging and Alzheimer’s dementia: a 18F-FDG-PET study of brain and cognitive reserve. Hum Brain Mapp. 2017;38(8):4212–27.
PubMed
PubMed Central
Google Scholar
Chung J, Yoo K, Kim E, Na DL, Jeong Y. Glucose metabolic brain networks in early-onset vs late-onset Alzheimer’s disease. Front Aging Neurosci. 2016;8:159.
PubMed
PubMed Central
Google Scholar
Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27(8):402–9.
CAS
PubMed
Google Scholar
Amor S, Puentes F, Baker D, Van Der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129(2):154–69.
CAS
PubMed
PubMed Central
Google Scholar
Cerami C, Iaccarino L, Perani D. Molecular imaging of neuroinflammation in neurodegenerative dementias: the role of in vivo PET imaging. Int J Mol Sci. 2017;18(5):993.
PubMed Central
Google Scholar
Fan Z, Okello AA, Brooks DJ, Edison P. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer’s disease. Brain. 2015;138(12):3685–98.
PubMed
Google Scholar
Fan Z, Aman Y, Ahmed I, et al. Influence of microglial activation on neuronal function in Alzheimer’s and Parkinson’s disease dementia. Alzheimers Dement. 2015;11(6):608–21.
PubMed
Google Scholar
Kreisl WC, Lyoo CH, McGwier M, et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease. Brain. 2013;136(7):2228–38.
PubMed
PubMed Central
Google Scholar
Kreisl WC, Lyoo CH, Liow J, et al. 11C-PBR28 binding to translocator protein increases with progression of Alzheimer’s disease. Neurobiol Aging. 2016;44:53–61.
CAS
PubMed
PubMed Central
Google Scholar
Matarrese M, Moresco RM, Cappelli A, et al. Labeling and evaluation of N-[11C] methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors. J Med Chem. 2001;44(4):579–85.
CAS
PubMed
Google Scholar
Della Rosa PA, Cerami C, Gallivanone F, et al. A standardized [18 F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics. 2014;12(4):575–93.
PubMed
Google Scholar
Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6(4):279–87.
CAS
PubMed
Google Scholar
Presotto L, Iaccarino L, Bettinardi V, Gianolli L, Perani D. An automated clustering algorithm for reference region extraction of brain 11 C-PK11195 studies. In: 2015 IEEE nuclear science symposium and medical imaging conference (NSS/MIC). IEEE; 2015:1–3.
Turkheimer FE, Edison P, Pavese N, et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J Nucl Med. 2007;48(1):158–67.
PubMed
Google Scholar
Passamonti L, Tsvetanov KA, Jones PS, et al. Neuroinflammation and functional connectivity in Alzheimer’s disease: interactive influences on cognitive performance. J Neurosci. 2019. doi: https://doi.org/10.1523/JNEUROSCI.2574-18.2019.
Lee DS, Kang H, Kim H, et al. Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults. Eur J Nucl Med Mol Imaging. 2008;35(9):1681–91.
PubMed
Google Scholar
McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–9.
PubMed
PubMed Central
Google Scholar
Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–29.
PubMed
Google Scholar
Cagnin A, Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358(9280):461–7.
CAS
PubMed
Google Scholar
Edison P, Archer HA, Gerhard A, et al. Microglia, amyloid, and cognition in Alzheimer’s disease: an [11C](R) PK11195-PET and [11C] PIB-PET study. Neurobiol Dis. 2008;32(3):412–9.
CAS
PubMed
Google Scholar
Yokokura M, Mori N, Yagi S, et al. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2011;38(2):343–51.
CAS
PubMed
Google Scholar
Kreisl WC, Lyoo CH, Liow J-S, et al. Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer’s disease. Neurobiol Aging. 2017;51:132–40.
CAS
PubMed
Google Scholar
Lee CYD, Landreth GE. The role of microglia in amyloid clearance from the AD brain. J Neural Transm. 2010;117(8):949–60.
CAS
PubMed
Google Scholar
Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388–405.
CAS
PubMed
PubMed Central
Google Scholar
Brelstaff J, Tolkovsky AM, Ghetti B, Goedert M, Spillantini MG. Living neurons with tau filaments aberrantly expose phosphatidylserine and are phagocytosed by microglia. Cell Rep. 2018;24(8):1939–48.
CAS
PubMed
PubMed Central
Google Scholar